While AI coding startups like Cursor close brow-raising rounds on barely three years of existence, Replit's path to a $3 ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback